Recipharm has equipped its sixth facility with serialization capabilities ahead of the U.S. and European regulation enforcement deadlines. The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supplying serialized products to the U.S. and Europe, following a €40 million investment into its company-wide implementation program in 2016. Recipharm has delivered over 1.3 million serialized and aggregated packs to markets such as, China, South Korea, Saudi Arabia...